Latest Breaking News On - விஸ்கான்சின் முதுமறதி - Page 1 : comparemela.com

New insights into participation of underrepresented communities in Alzheimer’s clinical trials A significant hurdle in developing therapeutics and care models for Alzheimer s disease that work for people of all ethnic and racial backgrounds is the recruitment and retention of traditionally underrepresented groups in clinical trials. At the Alzheimer s Association International Conference ® (AAIC ®) 2021, in Denver and virtually, researchers shared new evidence-based insights into why people from communities of color do and do not choose to participate in clinical trials. Also at AAIC 2021, the National Institute on Aging (NIA), part of the U.S. National Institutes of Health, launched a new online tool, Outreach Pro, to help researchers and clinicians increase awareness and participation in clinical trials on Alzheimer s disease and other dementias, especially among traditionally underrepresented communities.

United statesUniversity of wisconsinCarlv hillFarrar edwardsHolly massettEmily hendersonDorothy farrar edwardsAlexandra mitchellSenior advisor on clinical research recruitmentResearch goalAlzheimer association international conferenceUs national institutes of healthUniversity of wisconsin collaborative centerDementias clinical researchClinical research coordinatorNational strategy for recruitment